About certus molecular diagnostics
certus molecular diagnostics is a company based in Zollikofen (Switzerland) founded in 2017. certus molecular diagnostics offers products and services including Molecular Rapid Tests. certus molecular diagnostics operates in a competitive market with competitors including Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.
- Headquarter Zollikofen, Switzerland
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website certusdiagnostics.com
- Social LinkedIn
- Legal Name Certus Molecular Diagnostics Ag
Products & Services of certus molecular diagnostics
certus molecular diagnostics offers a comprehensive portfolio of products and services, including Molecular Rapid Tests.
Rapid tests for detecting pathogens with 30-minute results and simple use.
Competitors of certus molecular diagnostics
certus molecular diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Karius, MeMed, Visby Medical and GenMark Diagnostics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inflammatix.com | 2016 | San Francisco, United States | $191.5M | 54 | Provider of diagnostic solutions for systemic infections | |
| kariusdx.com | 2014 | Redwood, United States | $315.0M | 139 | Developer of a non-invasive pathogen blood test for the detection of infectious diseases | |
| me-med.com | 2009 | Tirat Carmel, Israel | $163.0M | – | Provider of machine learning based diagnostic solutions for infectious diseases | |
| visbymedical.com | 2010 | San Jose, United States | $386.3M | 251 | Portable PCR diagnostics for infectious diseases are developed. | |
| genmarkdx.com | 1993 | San Diego, United States | $8.6M | 797 | Instruments and test panels for multiplexed molecular diagnostics are provided. | |
| sunbirdbio.com | 2020 | Singapore | $14.0M | – | Diagnostic technologies for infectious, cancer, and neurological diseases are developed. | |
| t2biosystems.com | 2006 | Lexington, United States | $454.3M | 166 | Miniaturized MRI platforms for clinical diagnostics are developed. | |
| biomeme.com | 2013 | Philadelphia, United States | $6.2M | 202 | Smartphone-based DNA detection platform is developed for diagnostics. | |
| biofiredx.com | 1990 | Salt Lake, United States | $84.0M | 8 | Molecular diagnostic solutions for genetic condition detection are provided. | |
| molbiodiagnostics.com | 2000 | Salcete, India | $124.0M | 714 | Point-of-care molecular platforms for infectious disease detection are developed. |
Detailed competitors of certus molecular diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to certus molecular diagnostics
10 companies that operate in the same segment as certus molecular diagnostics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about certus molecular diagnostics
certus molecular diagnostics was founded in 2017.
certus molecular diagnostics is headquartered in Zollikofen, Switzerland. It is registered at Zollikofen, Bern, Switzerland.
Certus Molecular Diagnostics was founded in 2017 and is based in Zollikofen, Switzerland. Operations focus on the molecular diagnostics sector, where rapid tests for identifying specific genes in microorganisms are developed and supplied. A proprietary isothermal amplification method combined with real-time detection is utilized. Ready-to-use reagents are offered, enabling targeted gene segments to be amplified isothermally and detected via a dsDNA-intercalating dye.
certus molecular diagnostics's top competitors include Visby Medical, Inflammatix and MeMed.
certus molecular diagnostics offers Molecular Rapid Tests.
certus molecular diagnostics operates through Certus Molecular Diagnostics Ag.